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Abstract: Tissue engineering, gene therapy, drug screening,
and emerging regenerative medicine therapies are fundamen-
tally reliant on high-quality adherent cell culture, but current
methods to cryopreserve cells in this format can give low cell
yields and require large volumes of solvent “antifreezes”.
Herein, we report polyproline as a minimum (bio)synthetic
mimic of antifreeze proteins that is accessible by solution,
solid-phase, and recombinant methods. We demonstrate that
polyproline has ice recrystallisation inhibition activity linked to
its amphipathic helix and that it enhances the DMSO
cryopreservation of adherent cell lines. Polyproline may be
a versatile additive in the emerging field of macromolecular
cryoprotectants.
Tissue engineering, gene therapy, therapeutic protein pro-
duction, and transplantation rely on the successful storage
and transport of donor cells.[1] For example, in the production
of therapeutic proteins, a specific cell line must be developed
for each protein.[2] Given that any in vitro culture will
undergo phenotypic and genotypic changes when propagated
for long periods of time, it is neither possible nor practical to
maintain a continuous culture of cells.[3] The only solution to
this is the cryopreservation of cells using significant volumes
of cryoprotectants, such as DMSO (dimethyl sulfoxide),
which are intrinsically toxic.[4] The repeated use of DMSO
has an impact on the epigenetic profile of cells, specifically the
alteration of DNA methylation profiles, which results in
phenotypic changes.[5,6] There is a real need for robust
methods to cryopreserve cells in monolayer (adhered to
tissue culture scaffolds) format to provide phenotypically
identical cells for assays, obviating the need for replating
between freeze–thaw cycles. Formulations containing 5–10%
DMSO reduce cryoinjury by moderating the increase in
solute concentration during freezing[7–9] but for adhered
embryonic stem cells, their use results in just 5% cell
recovery.[10, 11] A key contributor to cell death during cryo-
preservation is ice recrystallisation (growth) and additives
that can inhibit recrystallisation have the potential to redefine
cell storage and hence biomedicine.
Antifreeze (glyco)proteins (AF(G)Ps) are potent ice
recrystallisation inhibitors (IRIs), but are unsuitable for
cryopreservation applications owing to their potential tox-
icity/immunogenicity and their secondary effect of dynamic
ice shaping (DIS), which leads to needle-like ice crystals that
pierce cell membranes.[12] Synthetic polymers that are potent
IRIs have emerged as new tools for controlling ice growth.[13]
The most studied one is poly(vinyl alcohol) (PVA), which can
inhibit ice growth at concentrations below 0.1 mgmL@1 and
enhances the cryopreservation of cells in suspension.[14–16] It is
hypothesized that the activity of PVA is related to its
regularly spaced hydroxyl groups.[17] Matsumura and Hyon
have developed polyampholytes[18] that are cryoprotective but
have moderate IRI activity.[19,20] Wang and co-workers have
demonstrated the significant IRI activity of graphene
oxide.[21] Ben and co-workers have developed low-molecu-
lar-weight surfactants that also inhibit ice growth.[22] A major
setback is that the above synthetic IRIs are neither biode-
gradable nor bioresorbable and have not been applied to the
significant challenge of cell monolayer storage.
There are no crystal structures for AFGPs but solution-
state NMR and circular dichroism (CD) spectroscopy suggest
a polyproline II (PP II)-type helix.[23] Polyproline is unique
amongst the canonical amino acids in that it has no amide
N@H, meaning that it cannot form intramolecular hydrogen
bonds. Therefore, it is water-soluble and quite hydrophobic at
the same time, as is the case for AFP I, which contains 70%
alanine (a hydrophobic amino acid). We thus hypothesised
that polyproline could be a minimal AF(G)P mimic owing to
its amphiphilicity.[24] Homopolypeptides are appealing targets
compared to vinyl polymers as they can be prepared by solid-
phase synthesis,[25] solution-phase polymerisation,[26] or
recombinant methods,[27] proving vast (bio)synthetic space.
Herein, we introduce polyproline as a minimum (bio)-
synthetic antifreeze protein mimic. We demonstrate that
polyproline has ice recrystallisation inhibition activity, which
is linked to its amphipathic PP II helix structure. Polyproline
was found to improve the post-cryopreservation recovery of
cell monolayers compared to DMSO alone, demonstrating
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a new macromolecular approach for the storage of complex
cells to enable next-generation therapies.
l-, d-, and (racemic) d/l-polyproline were synthesised by
condensation polymerisation using 1-ethyl-3-(3-dimethylami-
nopropyl) carbodiimide (EDC, Scheme 1), alongside several
commercial samples. Following dialysis, the polymers were
characterised by size exclusion chromatography (SEC;
Table 1). The polymers were less disperse than expected
owing to fractionation during dialysis.
CD spectroscopy confirmed that PPro15 adopted a PP II
helix (Figure 1A; see also the Supporting Information, Fig-
ure S1)[31] with characteristic signals present at 207 and
228 nm, whilst a random coil would exhibit slight peak
shifting, with signals absent in the 220 nm region.[32] P(d-
Pro)15 gave the mirror spectrum whilst the d/l racemic
mixture showed no secondary structure. This series of
peptides were subsequently tested for IRI activity using
a splat assay.[33] This involved seeding a large number of small
ice crystals, which were annealed for 30 min at @8 8C before
being photographed. The average crystal size was measured
relative to a PBS control, with smaller values indicating more
IRI activity (Figure 1B,C).
All polyproline variants were found to display dose-
dependent activity but weak molecular-weight dependence in
the range tested (Figure 1B). The shortest peptide (PPro10)
lost activity below 10 mgmL@1, but the longer ones retained
activity at 5 mgmL@1. The magnitude of activity was signifi-
cantly smaller than for AF(G)Ps, which function at concen-
trations as low as 0.14 mgmL@1,[34] but comparable to that of
polyampholytes.[19, 20] Knight and co-workers have observed
that poly(hydroxyproline) has IRI activity, which was
assumed to be due to the regularly spaced hydroxyl groups
along the backbone.[35] However, the observations made here
suggest that the PP II helix, rather than (or in addition to) the
hydroxyl groups, gives rise to the observed activity. Figure 1C
compares the IRI activity of poly(hydroxyproline) with those
of PPro15 and two a-helical poly(amino acid)s.
[36] Polylysine
(PLys50) and poly(glutamic acid) (PGlu110) showed no IRI
activity. PPro15 was found to be more active than poly(hy-
droxyproline) of higher molecular weight. This finding
confirmed that hydroxyl groups are not essential for activity
in IRI-active compounds. P(d-Pro15) and P(d/l-Pro21) had
statistically identical activity to PPro15, suggesting that local
rather than long-range order is crucial for activity.
We hypothesise that IRI activity requires segregated
hydrophilic and hydrophobic domains (amphipathy).[37, 22,24]
PPro10 was compared to a non-glycosylated type I sculpin
AFP[38] and also to PGlu10 by mapping their hydrophobic/
hydrophilic domains (Figure 2). The type I sculpin AFP
(Figure 2A) possesses “patches” of hydrophobic/hydrophilic
groups. PPro10 (Figure 2B) also possesses this facial amphi-
Scheme 1. Condensation polymerisation of proline. The materials were
used in stereopure form but both the l- and d-isomers were used,
hence no stereocentres are shown.
Table 1: Polyproline characterisation.
Mn
[gmol@1]
XSEC [a] DP Secondary
structure
PPro11 1300
[a] 1.03 11
PP IIPPro15 1700
[a] 2.12 15
PPro19 2100
[a] 1.50 19
P(d-Pro)15 1700
[a] 1.01 15 enantiomeric PP II
P(d/l-Pro)21 2400
[a] 1.01 21 random coil
PPro10-100 1–10000
[b] – 10–100 PP II[e]
PPro10 900
[c] [d] 10 PP II[e]
PPro10-25 1–3000 1.01–1.03 10–25 PP II
[e]
PPro20 2000
[c] [d] 20 PP II[e]
[a] Determined by SEC. [b] Value from supplier. [c] Determined by mass
spectrometry. [d] Single species. [e] From Ref. [28–30].
Figure 1. A) Circular dichroism spectra. B) IRI activity of the polypro-
line series. C) IRI activity compared to other homopolypeptides.
D) Cryomicrograph of a PBS negative control. E) Cryomicrograph of
20 mgmL@1 polyproline. Photographs taken after 30 min at @8 8C.
Error bars represent : standard deviation from a minimum of three
replicates. Images shown are 1.2 mm across. MLGS=mean largest
grain size.
Figure 2. Hydrophobic surface mapping of A) recombinant type I scul-
pin AFP, B) PPro10, and C) PGlu10, showing charged hydrophilic surfa-
ces. Hydrophobic regions (red), hydrophilic regions (white).
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philicity. In comparison, PGlu10 (no IRI activity) has charged
groups around the core of the helix, which prevents the
presentation of hydrophobic domains. This agrees with our
previous study on nisin A, which has IRI activity associated
with segregated domains,[37] and also the results obtained with
amphiphiles developed by Ben et al., which only function
below the critical micelle concentration.[22]
Aside from IRI activity, AF(G)Ps display unwanted ice
shaping, which promotes the formation of needle-like ice
crystals, which damage cell membranes.[12] Cryo-confocal
microcapillary microscopy has emerged as a tool for mon-
itoring ice crystal shaping,[39] and was also employed here
(Figure 3). A non-IRI-active dye, sulforhodamine B, provided
contrast against the ice (which appears dark). A control using
pure PBS showed no shaping whilst zirconium acetate
(ZrAc), which is a strong ice shaper, produced hexagonal
crystals.[39] PPro19 did not induce shaping, supporting the
concept that polyproline inhibits ice crystal growth without
inhibiting the formation of a specific plane of ice; however, as
these are relatively weak IRIs, the concentrations needed for
ice shaping would be very high.
To explore polyproline as a macromolecular cryopreser-
vative, A549 cells were employed as a prototypical adherent
cell line.[40] The protective osmolyte proline (which has no IRI
activity; see the Supporting Information) was used as
a secondary cryoprotectant. A549 cells were incubated with
200 mm (23 mgmL@1) proline (blue bars; Figure 4) or medium
alone (red bars; Figure 4) for 24 h. The medium was then
removed and replaced with a medium containing 10%
DMSO with varying concentrations of PPro11 (1250 gmol
@1,
Y= 1.03). After 10 min exposure to this solution, all excess
solvent was removed, and the cells were subjected to
controlled-rate freezing at 1 8Cmin@1 to @80 8C. Following
storage at @80 8C, the cells were thawed by addition of warm
medium (37 8C), and the total number of viable cells was
determined by trypan blue staining 24 h after thawing.
Figure 4 shows that the use of DMSO alone led to 27% cell
recovery. Addition of polyproline alone to 10%DMSO failed
to give any additional protection. However, for cells that had
been preconditioned with 200 mm proline for 24 h before
treatment with 10 mgmL@1 PPro11/10% DMSO, the cell
recovery doubled to 53%. Increasing the concentration of
polyproline beyond 10 mgmL@1 did not increase recovery
further, suggesting that the additive benefits plateau at
10 mgmL@1.[14] It should be highlighted that the cell viability
assays measure intact cells, and that detailed functional
analysis will be needed in the future for demonstration of
complex function. For comparison with other macromolecu-
lar cryopreservatives, Matsumura and co-workers have
reported poly(ampholyte)-enhanced monolayer storage
using vitrification solutions, giving near-quantitative cell
recovery.[41] However, this required very high DMSO con-
centrations of 6.5m (> 500 mgmL@1) plus 10 wt% (ca.
100 mgmL@1) of the polymer, and there was a reduction in
the post-thaw proliferation rate associated with the large
solvent volumes, which may limit practical applications. In our
PPro system introduced here, the total recovery levels were
less, but far lower concentrations of DMSO were employed
(10 wt%/ca. 100 mgmL@1), and the total exposure time to this
potentially toxic component was only 10 min. To critically
compare PPro, another batch (PPro10–25) was synthesised and
tested for cytotoxicity and heamocompatibility. A549 mono-
layers were exposed to PPro for 24 h, and the cell viability was
assessed (see the Supporting Information). This extended
exposure period led to a reduction in alamar blue to 60% for
5 mgmL@1 PPro, suggesting some cytotoxicity if exposed to
elevated concentrations for long periods of time. It is
important to note that in this cryopreservation procedure,
PPro is only in contact with the cells for 10 min before the
excess is removed and the cells are frozen. Red blood cell
heamolysis experiments (see the Supporting Information)
Figure 3. Cross-section of ice crystals perpendicular to the temperature
gradient: A) ZrAc (positive control), B) PPro19, C) PBS (negative con-
trol). The ice crystals expel the dye while growing, appearing in black,
while the remaining liquid fluoresces.
Figure 4. A549 cryopreservation. Cell recovery determined by trypan
blue assays. Cells were first incubated either in the medium alone or
with 200 mm proline for 24 h. They were subsequently cryopreserved
by addition of 10% DMSO with the indicated PPro11 concentration.
Error bars : S.E.M. from n=3 with two nested replicates. # P<0.05
compared to 10% DMSO treatment; * P<0.05 compared to 200 mm
proline exposure with 10% DMSO treatment.
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showed this was not due to any inherent membrane activity of
the (amphipathic) PPro.
In summary, we have demonstrated that polyproline is
a potent additive for cell-monolayer cryopreservation when
appropriate freezing conditions are employed. Polyproline
has moderate ice recrystallisation inhibition activity, which
was hypothesised to be due to its “patchy” amphipathic
structure associated with its PP II helix. Addition of polypro-
line to adherent cell cultures led to an increase from 20% to
> 50% in total cell recovery post-cryopreservation, which is
significantly better than for the use of DMSO alone. This
increase in recovery is thought to be associated with the
inhibition of ice recrystallisation. Short exposure times of just
10 min to the polyproline/DMSO solution, followed by
removal of the excess solvent, reduced the cytotoxicity
associated with long-term (24 h) exposure to elevated levels
of polyproline. The minimal solvent exposure times may give
benefits in downstream processing and biomedical applica-
tions compared to current high-solvent-concentration meth-
ods using vitrification. Polyproline is appealing compared to
other macromolecular cryoprotectants as it only comprises
native amino acids and can be obtained by chemical and
biochemical methods.
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